dihexa clinical trials status 2026 human or studies dihexa human clinical trials or studies dihexa clinical trials International Clinical Trials Day 2026

To meet the diagnostic criteria for pEDS, a person must meet: Major criterion 1 AND two other major criteria AND one minor criterion OR Major criterion 2 AND two other major criteria AND one minor criterion Major Criteria Severe and intractable periodontitis of early onset (childhood or adolescence) Lack of attached gingiva Pretibial plaques Family history of a first-degree relative who meets the clinical diagnostic criteria for pEDS Minor Criteria Easy bruising Joint hypermobility, mostly distal joints Skin hyperextensibility and fragility, abnormal scarring (wide or atrophic) Increased rate of infections Hernias Marfanoid facial features Acrogeria Prominent vasculature Spondylodysplastic EDS (spEDS) If a person meets the diagnostic criteria for spEDS, genetic testing should be done to confirm the diagnosis

Oral BPC-157 There are two main forms of BPC-157 treatment: injectable and oral

Its important for doctors and patients to know these rules

While the study found changes in GFAP and synaptophysin, confirming structural modulation, the behavioral assay does not strictly isolate memory from reduced anxiety or improved locomotion

Combining amylin-like effects with incretin-based effects may strengthen appetite control for some people